The global diabetic retinopathy market was valued at $3.09 billion in 2020 and is projected to reach $10.79 billion by 2030, growing at a robust CAGR of 13.7%.
Diabetic retinopathy (DR) remains the leading cause of vision loss and blindness in people of working age, in spite of the fact that current treatments are effective. Vision loss occurs in DR due ...
Avant Technologies' Partner, Ainnova, Signs Pilot Program with Roche to Combat Diabetic Retinopathy Avant Technologies, Inc. (OTCQB: AVAI), an emerging technology company developing solutions in ...
The global prevalence of diabetes continues to rise, projected to impact 700 million individuals by 2045. This increase parallels a significant growth in diabetes-associated complications, with ...
Keeping your blood glucose levels and blood pressure under control, for example, can help. Diabetic retinopathy, or eye disease, can cause vision loss and blindness. High blood glucose levels can ...